Prise en charge des événements indésirables chez les patients sous traitement par immunoglobulines : recommandations pour la pratique clinique

Marie, I.; Chérìn, P.; Michallet, Mauricette; Pelus, E.; Dantal, Jacques; Crave, Jean-Charles; Delain, Jean-Christophe; Viallard, J.-F.

doi:10.1016/j.revmed.2016.10.390

Cited by 9 publications

(2 citation statements)

References 73 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Common and mild side effects23)24)25) include hypertension, headache, malaise, nausea, low-grade fever and chills, urticaria, arthralgias, and myalgia. These symptoms typically resolve within several days after onset.…”

Section: The Safety Of High-dose Intravenous Immunoglobulinmentioning

confidence: 99%

“…These symptoms typically resolve within several days after onset. Rare and serious side effects23)24)25) include immunoglobulin A deficiency-related anaphylactic reactions, aseptic meningitis, acute renal failure, stroke, myocardial infarction, and thrombotic complications. A thorough medical evaluation must be performed for every KD patient being evaluated for high-dose IVIG therapy.…”

Section: The Safety Of High-dose Intravenous Immunoglobulinmentioning

confidence: 99%

See 1 more Smart Citation

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

Han

2017

Korean Circ J

View full text Add to dashboard Cite

Section: The Safety Of High-dose Intravenous Immunoglobulinmentioning

confidence: 99%

Section: The Safety Of High-dose Intravenous Immunoglobulinmentioning

confidence: 99%

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

Han

2017

Korean Circ J

View full text Add to dashboard Cite

Pain, Headache, and Other Non-motor Symptoms in Myasthenia Gravis

Tong

Delfiner

Herskovitz

2018

Curr Pain Headache Rep

View full text Add to dashboard Cite

Work in this area has been limited. Recent studies have identified bodily pain and headache as common complaints in patients with MG. A growing literature also suggests that there may be an association of MG and sleep disturbance (both obstructive sleep apnea and sleep cycle dysfunction). Few studies suggest some measurable abnormalities of olfaction, gustation, audition, and autonomic function. The cognitive and psychosocial aspects of MG represent an emerging area of clinical and research interest, but large-scale data is sparse in the USA. The pathophysiology of MG is complex, and our understanding of the immunologic basis of this disease is expanding. The classic view of MG as a purely motor disorder may be incomplete. Recent work highlights non-motor symptoms that may impact patient management and quality of life.

show abstract

Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: A comparative study in 52 patients

Chaigne

Rodeia

Benmostefa

et al. 2020

Autoimmunity Reviews

View full text Add to dashboard Cite

Prise en charge des événements indésirables chez les patients sous traitement par immunoglobulines : recommandations pour la pratique clinique

Cited by 9 publications

References 73 publications

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

Pain, Headache, and Other Non-motor Symptoms in Myasthenia Gravis

Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: A comparative study in 52 patients

Contact Info

Product

Resources

About